A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative Colitis

Clinical trial NCT00616434 · COMPLETED

Trial details

NCT number: NCT00616434
Sponsor: Biogen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Active Ulcerative Colitis

Start date: 2008-05-01
Primary completion: 2010-03-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.